Campus, Miralyn .
HRN: 27-29-25 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/09/2025
CEFUROXIME 1.5GM (VIAL)
06/09/2025
06/09/2025
IVT
1.5 G
PTOR
STAT CS
Checking Initial Appropriateness
06/11/2025
CEFUROXIME 1.5GM (VIAL)
06/11/2025
06/13/2025
IV
1.5
Q8
SP LTCS
Checking Initial Appropriateness
06/11/2025
MUPIROCIN 2%, 15G (TUBE)
06/11/2025
06/15/2025
TOPICAL
Apply On Surgical Site
Daily
Post Op Prophylaxis
Checking Initial Appropriateness
06/13/2025
CEFUROXIME 500MG (TAB)
06/13/2025
06/19/2025
PO
500mg
BID
CS
Checking Initial Appropriateness
06/16/2025
CEFUROXIME 500MG (TAB)
06/16/2025
06/20/2025
PO
500mg
BID
SP CS
Checking Initial Appropriateness